SLC17A9 Knockout Huh-7 Cell Line
Cat.No.:
EDC08601
Species:
Human
Cell Name:
Huh-7
Gene:
SLC17A9
Gene ID:
63910
Size:
1×10⁶cells
SLC17A9 Knockout Huh-7 Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC08601 |
|---|---|
| Product Name | SLC17A9 Knockout Huh-7 Cell Line |
| Species | Human |
| Cell Line | Huh-7 |
| Cellosaurus ID | CVCL_0336 |
| Gene ID | |
| Cell Line Synonyms | HuH-7, HUH-7, HuH7, Huh7, HUH7, HUH7.0, JTC-39, Japanese Tissue Culture-39 |
| Gene | SLC17A9 |
| Summary |
This gene encodes a member of a family of transmembrane proteins that are involved in the transport of small molecules. The encoded protein participates in the vesicular uptake, storage, and secretion of adenoside triphosphate (ATP) and other nucleotides. A mutation in this gene was found in individuals with autosomal dominant disseminated superficial actinic porokeratosis-8. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014]
|
| Digestion Time | 2 min |
| Morphology | Adherent |
| Passage Ratio | 1:3 |
| Complete Culture Medium | DMEM + 10% FBS |
| Freezing Medium | 70% Complete medium + 20% FBS + 10% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: Huh-7 | STR Info (Cell bank) Cell Line: Huh-7 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1P0 | 11 | 11 | ||
| D2S1338 | 19 | 19 | ||
| D3S1358 | 15 | 15 | ||
| D5S818 | 12 | 12 | ||
| D7S820 | 11 | 11 | ||
| D8S1179 | 14 | 14 | 15 | |
| D13S317 | 10 | 11 | 10 | 11 |
| D16S539 | 10 | 10 | ||
| D18S51 | 15 | 15 | ||
| D19S433 | 13 | 14 | 13 | 14 |
| D21S11 | 30 | 30 | ||
| FGA | 22 | 23 | 22 | 23 |
| Penta D | 12 | 12 | ||
| Penta E | 11 | 11 | ||
| TH01 | 7 | 7 | ||
| TPOX | 8 | 11 | 8 | 11 |
| vWA | 16 | 18 | 16 | 18 |
| D6S1043 | 13 | 15 | 13 | 15 |
| D12S391 | 20 | 21 | 20 | 21 |
| D2S441 | 12 | 14 | 12 | 14 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying SLC17A9 function, SLC17A9 Knockout Huh-7 Cell Line or SLC17A9 overexpression Huh-7 Cell Line?
The choice depends on whether you are studying SLC17A9 (VNUT, vesicular nucleotide transporter)'s role in vesicular ATP loading and purinergic signaling or its emerging functions in metabolic disease and cancer. The Knockout line is the standard tool for asking whether VNUT is required for vesicular ATP storage — VNUT is the principal vesicular ATP transporter, essential for purinergic ATP release from many cell types. Overexpression is useful for testing ATP storage capacity or for studying VNUT trafficking.
For purinergic signaling research, the EDITGENE VNUT Knockout in Huh-7 enables study of hepatic ATP release and downstream purinergic effects on insulin sensitivity and glucose metabolism. VNUT inhibitors (clodronate, others) specificity testing benefits from this knockout. Rescue with wild-type or transport-deficient VNUT enables structure-function studies. VNUT has emerging therapeutic interest in metabolic disease.
What are the application scenarios for this model?
Primary applications:
• Vesicular ATP storage: cellular ATP content in secretory vesicles and ATP release assays to quantify VNUT-dependent vesicular loading.
• Purinergic signaling: extracellular ATP measurement following stimulation to assess VNUT-dependent ATP release.
• Hepatic metabolism: glucose and insulin sensitivity studies in hepatocyte-derived context given VNUT's reported role in hepatic nucleotide release.
• VNUT inhibitor specificity: clodronate specificity testing with the knockout as critical genetic control.
EDITGENE recommends this model for researchers investigating vesicular nucleotide transport, purinergic signaling, and metabolic disease mechanisms.
Is this SLC17A9 Knockout Huh-7 Cell Line compatible with overexpression rescue experiments?
Yes. VNUT rescue experiments require attention to vesicular targeting:
• Construct design: use a codon-modified SLC17A9 sequence with a small C-terminal tag (FLAG, HA). VNUT has 12 transmembrane domains.
• Vesicular localization validation: confirm secretory vesicle/lysosomal localization by imaging before functional assays.
• Transport-deficient rescue: substrate-binding pocket mutations enable structure-function studies of ATP transport.
• Functional readout: rescue should restore vesicular ATP storage and stimulated ATP release.
Huh-7 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.